Skip to main content
Shanghai Medicilon Inc. logo

Shanghai Medicilon Inc. — Investor Relations & Filings

Ticker · 688202 ISIN · CNE100003NQ8 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 817 across all filing types
Latest filing 2021-04-23 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 688202

About Shanghai Medicilon Inc.

https://www.medicilon.com.cn/

Shanghai Medicilon Inc. is a comprehensive contract research organization providing integrated drug discovery and development services to the global pharmaceutical and biotechnology sectors. The company offers a full spectrum of preclinical services, including medicinal chemistry, lead optimization, in vitro and in vivo biology, pharmacology, and drug metabolism and pharmacokinetics (DMPK). Medicilon specializes in safety evaluation and toxicology studies conducted in GLP-compliant facilities to support Investigational New Drug (IND) applications. Its integrated platform facilitates the transition of drug candidates from initial discovery through preclinical development, covering both small molecule drugs and biologics. By leveraging advanced technology and scientific expertise, the company assists clients in accelerating drug development timelines and optimizing research outcomes.

Recent filings

Filing Released Lang Actions
美迪西：2021年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled '2021 年第一季度报告' which translates to '2021 First Quarter Report'. It contains detailed financial data including balance sheet items, profit and loss statement items, cash flow statement items, and explanations of significant changes. The document is 6942 characters long, which is sufficient to contain substantive financial data. It explicitly states it is a quarterly report and includes comprehensive financial figures and analysis for the first quarter of 2021. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2021
2021-04-23 Chinese
美迪西：第二届监事会第十三次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 13th meeting of the 2nd Supervisory Board of Shanghai Medicilon Inc. It includes approval of the 2020 Supervisory Board Work Report, the 2020 Financial Final Accounts Report, the 2020 Profit Distribution Plan, the 2020 Annual Report and its summary, a special report on the use of raised funds, and other related matters. The document contains specific financial figures for 2020 and detailed voting results. However, it is not the annual report itself but a meeting resolution announcement that references the annual report and other reports which are published separately on the Shanghai Stock Exchange website. The document length is 2689 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the MENU VS MEAL RULE, this document is best classified as a Regulatory Filing (RNS) because it is an official regulatory announcement of supervisory board meeting resolutions and approvals, not the full annual report or financial statements themselves.
2021-04-15 Chinese
美迪西：立信会计师事务所（特殊普通合伙）关于上海美迪西生物医药股份有限公司2020年度非经营性资金占用及其他关联资金往来情况的专项报告
Regulatory Filings
2021-04-15 Chinese
美迪西：2020年年度报告
Annual Report Classification · 100% confidence The document is titled '2020 年年度报告' which translates to '2020 Annual Report'. It contains detailed sections typical of an annual report such as company overview, financial data, risk factors, profit distribution plans, governance, and detailed financial statements. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. It includes audited financial data, management discussion, and comprehensive business descriptions. The presence of audit opinions and detailed financial metrics further supports this classification. Therefore, this document is the official yearly report covering company activity and full financial performance, matching the definition of an Annual Report (10-K). FY 2020
2021-04-15 Chinese
美迪西：关于使用部分超募资金永久补充流动资金的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Shanghai Medicilon Inc. regarding the use of part of the company's over-raised funds to permanently supplement working capital. It details board and supervisory committee meetings, approvals, independent director opinions, and compliance with regulatory guidelines on the use of raised funds. The document does not contain financial statements or detailed financial results but focuses on the company's capital usage decisions and regulatory compliance disclosures. It is a regulatory announcement about capital usage rather than a financial report or earnings release. Given the content and length (3916 characters), it fits best as a Capital/Financing Update (CAP) filing type, which covers updates on company fundraising and capital structure changes.
2021-04-15 Chinese
美迪西：独立董事关于第二届董事会第十四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on various company matters discussed at a board meeting, including profit distribution, use of raised funds, appointment of auditors, remuneration plans, internal control evaluation, accounting policy changes, and cash management. It references compliance with laws and regulations and provides independent opinions on proposals to be submitted to the shareholders' meeting. The content is focused on governance and board-level decisions rather than financial results or audit reports themselves. The document is not a full annual report, audit report, or earnings release, nor is it a simple announcement. It fits best as Board/Management Information (MANG) because it concerns board meeting matters and independent director opinions on governance and management proposals.
2021-04-15 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.